Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(216)
•••
13X2413
X
View Profile
View Bullboard History
Comment by
13X2413
on Nov 12, 2024 12:42pm
RE:RE:RE:RE:Today’s News
In a way, I'm not shocked that Azz, Not, CF have not chimed in on the latest BS news. Even they must be concerned. Noteless doesn't even bother to comment, instead goes right to the
...more
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 12, 2024 12:38pm
RE:RE:RE:Today’s News
Here we go with more worthless mumbo jumbo from ole unnoteable.
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 12, 2024 12:28pm
RE:RE:RE:Immunology wars: Tumor Microenvironment - simply xplained
The tumor microenvironment plays a critical role in cancer progression and resistance to treatment. The tumor microenvironment (TME) is one of the most formidable obstacles in the fight
...more
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 12, 2024 12:18pm
RE:RE:Today’s News
Crickets from the pumpers this morning. I agree... but they are running out of capital so will have to do something to raise funds in the near future. Deluting may occur as a result of raising capital
...more
(112)
•••
spesestsemper
X
View Profile
View Bullboard History
Comment by
spesestsemper
on Nov 12, 2024 11:36am
RE:Today’s News
Disappointing call today . They can't seem to get anyone interested in the company .No sense of them wanting to get anything done . Christophe is a big let down . Holding for now but maybe
...more
(95)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Nov 12, 2024 11:31am
RE:RE:RE:RE:ONCY prepares for Accelerated Approval
certain indicators, such as having statsically relevant data regarding PFS... and that for the number needed will take .... oh yes... aboiut 2 years to gather....
(95)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Nov 12, 2024 11:29am
RE:Today’s News
If cash burn is 9 million a quarter, that leaves 14 1/4 million now... which means sometme Q2 the lights go out... oh dear.
(112)
•••
spesestsemper
X
View Profile
View Bullboard History
Post by
spesestsemper
on Nov 12, 2024 11:29am
Jp morgan
Just before the 29 minute mark , christophe makes a comment about jp morgan . I could not make it out . Did anyone hear what he said about jp morgan ??
(13)
•••
Quantum41
X
View Profile
View Bullboard History
Comment by
Quantum41
on Nov 12, 2024 9:25am
RE:Today’s News
3 points jumped out for me today; 1. Accelerated approval timing (Kirk) enrollment over 18 month, plus 6 month study. That means 24 month until decision for accel. approval? So we are talking middle
...more
(216)
•••
13X2413
X
View Profile
View Bullboard History
Post by
13X2413
on Nov 12, 2024 7:45am
Today’s News
Certainly nothing close to what we hoped for. It's clear they're stretching their timelines well into 25. This jumps out, the question is, then what??????? As of September 30
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 12, 2024 7:02am
New Press Release - Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
BRACELET-1 data showing impressive overall survival benefit in HR+/HER2- metastatic breast cancer affirms pelareorep + paclitaxel combination should be evaluated in a registrational studyUpcoming GOBLET milestones include updated efficacy data from anal cancer cohort and safety run-in data from...
read article.
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 11, 2024 10:16pm
RE:RE:RE:worth repeating
I just love all the pumpers posts.... right up to the point nothing happens but they swear its eminent.
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 11, 2024 9:03pm
RE:RE:RE:ONCY prepares for Accelerated Approval
Canadafan posted - " Accelrated approval can hapen at anytime during the trial if certian indicators are met.*** The two year time line being posted is not based on any facts. Example being the
...more
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 11, 2024 8:53pm
RE:RE:worth repeating
Canuckcluck et al... has been posting this same ole stuff fir the last 5 years saying the buyout is eminent... crying wolf... no one believes you girls now... maybe something will happen but it
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden